These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16435129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.
    Miyagawa N, Kono K, Mimura K, Omata H, Sugai H, Fujii H.
    Oncology; 2006; 70(1):54-62. PubMed ID: 16446550
    [Abstract] [Full Text] [Related]

  • 3. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
    Yamaguchi H, Tanaka F, Ohta M, Inoue H, Mori M.
    Clin Cancer Res; 2004 Feb 01; 10(3):890-6. PubMed ID: 14871964
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
    Oiso M, Eura M, Katsura F, Takiguchi M, Sobao Y, Masuyama K, Nakashima M, Itoh K, Ishikawa T.
    Int J Cancer; 1999 May 05; 81(3):387-94. PubMed ID: 10209953
    [Abstract] [Full Text] [Related]

  • 6. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
    Akiyama Y, Maruyama K, Mochizuki T, Sasaki K, Takaue Y, Yamaguchi K.
    Immunol Lett; 2002 Aug 01; 83(1):21-30. PubMed ID: 12057851
    [Abstract] [Full Text] [Related]

  • 7. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M, Chikamatsu K, Katsura F, Obata A, Sobao Y, Takiguchi M, Song Y, Appella E, Whiteside TL, DeLeo AB.
    Clin Cancer Res; 2000 Mar 01; 6(3):979-86. PubMed ID: 10741724
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.
    Kobayashi J, Torigoe T, Hirohashi Y, Idenoue S, Miyazaki A, Yamaguchi A, Hiratsuka H, Sato N.
    J Transl Med; 2009 Jan 06; 7():1. PubMed ID: 19123955
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Generation of HER2 specific, HLA-A24 restricted CTLs derived from gastric cancer patients].
    Mimura K, Kono K, Sugai H, Miyagawa N, Omata H, Fujii H, Matsumoto Y.
    Gan To Kagaku Ryoho; 2003 Oct 06; 30(11):1802-4. PubMed ID: 14619524
    [Abstract] [Full Text] [Related]

  • 14. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
    Matsueda S, Takedatsu H, Yao A, Tanaka M, Noguchi M, Itoh K, Harada M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6933-43. PubMed ID: 16203785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes.
    Ikuta Y, Okugawa T, Furugen R, Nagata Y, Takahashi Y, Wang L, Ikeda H, Watanabe M, Imai S, Shiku H.
    Int J Cancer; 2000 Aug 15; 87(4):553-8. PubMed ID: 10918197
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of individual specific cytotoxic T lymphocytes for two MAGE-3-derived epitopes presented by HLA-A24.
    Katsura F, Eura M, Chikamatsu K, Oiso M, Yumoto E, Ishikawa T.
    Jpn J Clin Oncol; 2000 Mar 15; 30(3):117-21. PubMed ID: 10798537
    [Abstract] [Full Text] [Related]

  • 20. Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas.
    Tanaka H, Tsunoda T, Nukaya I, Sette A, Matsuda K, Umano Y, Yamaue H, Takesako K, Tanimura H.
    Br J Cancer; 2001 Jan 05; 84(1):94-9. PubMed ID: 11139320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.